Summary
This article discusses a study was to evaluating the efficacy of ledipasvir/sofosbuvir fixed-dose combination in treatment-experienced patients with hepatitis C virus genotype 1 who failed to achieve SVR at week 12 with prior sofosbuvir-based therapy.
- Viral Infections Hepatology Clinical Trials
- Liver Conditions
- Viral Infections
- Hepatology
- Hepatology Clinical Trials
- Liver Conditions
- © 2014 MD Conference Express®
Tools
100% SVR with Ledipasvir/Sofosbuvir Plus Ribavirin in Patients with HCV GT-1 Failing Prior Therapy
Permalink:
Table of contents
Cited By...
- No citing articles found.